Brown, Lisle/Cummings’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.12M | Buy |
75,568
+1,175
| +2% | +$126K | 2.16% | 7 |
|
|
2025
Q1 | $7.5M | Sell |
74,393
-132
| -0.2% | -$13.3K | 2.18% | 8 |
|
|
2024
Q4 | $6.66M | Buy |
74,525
+833
| +1% | +$74.4K | 1.99% | 8 |
|
|
2024
Q3 | $6.18M | Buy |
73,692
+75
| +0.1% | +$6.29K | 1.88% | 9 |
|
|
2024
Q2 | $5.67M | Buy |
73,617
+250
| +0.3% | +$19.3K | 1.85% | 10 |
|
|
2024
Q1 | $5.02M | Buy |
73,367
+1,250
| +2% | +$85.6K | 1.71% | 11 |
|
|
2023
Q4 | $4.17M | Sell |
72,117
-100
| -0.1% | -$5.78K | 1.55% | 11 |
|
|
2023
Q3 | $3.81M | Buy |
72,217
+2,525
| +4% | +$133K | 1.73% | 12 |
|
|
2023
Q2 | $3.77M | Buy |
69,692
+6,625
| +11% | +$358K | 1.69% | 13 |
|
|
2023
Q1 | $3.16M | Buy |
63,067
+975
| +2% | +$48.8K | 1.6% | 14 |
|
|
2022
Q4 | $2.87M | Buy |
62,092
+1,275
| +2% | +$59K | 1.54% | 13 |
|
|
2022
Q3 | $2.36M | Sell |
60,817
-1,000
| -2% | -$38.7K | 1.38% | 17 |
|
|
2022
Q2 | $2.3M | Buy |
61,817
+2,475
| +4% | +$92.2K | 1.28% | 20 |
|
|
2022
Q1 | $2.63M | Buy |
59,342
+5,225
| +10% | +$231K | 1.26% | 20 |
|
|
2021
Q4 | $2.3M | Buy |
+54,117
| New | +$2.3M | 1.15% | 20 |
|